The Association of Interleukin‐36 Staining Intensity and Response to Biologic Therapy in Patients With Psoriasis: A Retrospective Immunohistochemical and Chart Review Pilot Study
Patients with psoriasis with high IL-36 expression were more likely to respond to IL-12/23 and IL-23 inhibition than those with low IL-36, though these findings were not statistically significant. Additional studies with larger sample sizes are needed to validate and expand upon these findings.
Authors
- William R. Zhang
- Tina Bhutani (ORCID: https://orcid.org/0000-0001-8187-1024)
- Jeffrey P. North (ORCID: https://orcid.org/0000-0003-3973-5314)
Institutions
- University of California, San Francisco (US)
Publication Details
- Journal
- Journal of Cutaneous Pathology
- Published
- 2024-10-08
- DOI
- https://doi.org/10.1111/cup.14729
- Citations
- 1
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.24